{"resourceType": "ArtifactAssessment", "id": "179693", "meta": {"versionId": "11", "lastUpdated": "2025-09-07T21:27:56.348Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/certainty-of-evidence", "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-assessment"]}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-description", "valueMarkdown": "This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence."}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "179693", "assigner": {"display": "Computable Publishing LLC"}}], "title": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "artifactReference": {"reference": "Evidence/55", "type": "Evidence", "display": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)"}, "content": [{"type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "rating-system", "display": "Rating System"}]}, "classifier": [{"coding": [{"system": "http://hl7.org/fhir/uv/ebm/CodeSystem/evidence-rating-system-classifier-codesystem", "code": "GRADE", "display": "GRADE"}]}], "freeToShare": true}, {"type": {"coding": [{"system": "http://hl7.org/fhir/certainty-type", "code": "Overall", "display": "Overall certainty"}]}, "classifier": [{"coding": [{"system": "http://hl7.org/fhir/certainty-rating", "code": "low", "display": "Low quality"}]}], "freeToShare": true}], "citeAs": "Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-09-07. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json.", "text": {"status": "additional", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>&nbsp;Low certainty evidence (GRADE)</p></div>"}}